NI, YONG,YELESWARAM, KRISHNASWAMY,ERICKSON-VIITANEN, SUSAN,WILLIAMS, WILLIAM V.,PARIKH, BHAVNISH
申请号:
PE0006242015
公开号:
PE11572015A1
申请日:
2013.11.14
申请国别(地区):
PE
年份:
2015
代理人:
摘要:
The Invention relates to formulations and sustained release dosage forms of ruxolitinib or its pharmaceutically acceptable Salt, which are useful in the treatment of diseases related to the Janus kinase as myeloproliferative disordersLa invencion se refiere a formulaciones de liberacion sostenida y formas de dosificacion de ruxolitinib o su sal farmaceuticamente aceptable, que son utiles en el tratamiento de enfermedades relacionadas con las quinasa Janus como trastornos mieloproliferativos